Header cover image
  • Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

3

0 new

High return on equity, past performance and sound balance sheet.

3 companies

EZZ Life Science Holdings

Market Cap: AU$101.0m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

EZZ

AU$2.20

7D

2.3%

1Y

29.4%

Cryosite

Market Cap: AU$36.6m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$0.75

7D

5.6%

1Y

-18.5%

NeuroScientific Biopharmaceuticals

Market Cap: AU$73.2m

Engages in the research and development of novel peptide-based pharmaceutical products.

NSB

AU$0.24

7D

14.3%

1Y

500.0%